Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.14 USD | -1.60% | +4.73% | +92.14% |
May. 13 | Apogee Therapeutics' Q1 Net Loss Widens | MT |
May. 13 | Apogee Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+92.14% | 3.16B | |
+28.99% | 49.18B | |
+0.82% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.30% | 26.09B | |
-22.63% | 18.71B | |
+8.06% | 13.26B | |
+32.17% | 12.32B | |
-0.52% | 11.99B |
- Stock Market
- Equities
- APGE Stock
- News Apogee Therapeutics, Inc.
- Jefferies Adjusts Price Target on Apogee Therapeutics to $75 From $37, Maintains Buy Rating